Correlation Between Senti Biosciences and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Senti Biosciences and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Senti Biosciences and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Senti Biosciences and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Senti Biosciences and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Senti Biosciences with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Senti Biosciences and Mineralys Therapeutics,.
Diversification Opportunities for Senti Biosciences and Mineralys Therapeutics,
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Senti and Mineralys is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Senti Biosciences and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Senti Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Senti Biosciences are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Senti Biosciences i.e., Senti Biosciences and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Senti Biosciences and Mineralys Therapeutics,
Given the investment horizon of 90 days Senti Biosciences is expected to generate 4.46 times more return on investment than Mineralys Therapeutics,. However, Senti Biosciences is 4.46 times more volatile than Mineralys Therapeutics, Common. It trades about 0.02 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.01 per unit of risk. If you would invest 1,673 in Senti Biosciences on November 2, 2024 and sell it today you would lose (1,231) from holding Senti Biosciences or give up 73.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Senti Biosciences vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Senti Biosciences |
| Mineralys Therapeutics, |
Senti Biosciences and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Senti Biosciences and Mineralys Therapeutics,
The main advantage of trading using opposite Senti Biosciences and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Senti Biosciences position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
| Mineralys Therapeutics, vs. SEI Investments | Mineralys Therapeutics, vs. Carlyle Group | Mineralys Therapeutics, vs. Centessa Pharmaceuticals PLC | Mineralys Therapeutics, vs. Alto Neuroscience, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |